USING THE AP1 TRANSCRIPTION FACTOR FOSL1 TO ASSESS THE EXACERBATION OF PSORIASIS ArticleSobolev V.V., Soboleva A.G., Katkova K.V., Denisova Elena V., Zhukova Olga V., Potekaev Nikolay N., Sakanyia Luiza, Korsunskaya I.M., Mezentsev Alexandre V.Current Molecular Medicine. Том 25. 2025. С. 1534-1546
CCN3/NOV SERUM LEVELS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS IN COMPARISON WITH THE HEALTHY GROUP AND ITS CORRELATION WITH TNF-Α AND IL-6 ArticleAfrisham Reza, Alasvand Ghazal, Jadidi Yasaman, Farrokhi Vida, Moradi Nariman, Alizadeh Shaban H., Fadaei RezaCurrent Molecular Medicine. Том 25. 2025. С. 605-613
HGF, HNRPD, AND SFLT1 INTERFERE WITH THE INDUCTION OF VEGF IN PATIENTS WITH SEVERE PSORIASIS ArticleSobolev Vladimir, Muminova Madina, Zhukova Olga, Denisova Elena, Soboleva Anna, Potekaev Nikolay, Korsunskaya Irina, Mezentsev AlexandreCurrent Molecular Medicine. Том 24. 2024.